Q2 results Strong 2nd quarter. The Surgical Division sold for roughly 17.5 cents/share. Adjusted EBITDA for the next 12 months should be at least 6 cents/share and a conservative estimate of that value is 60 cents/share (10X). Meanwhile the shares closed today at 15 cents. Bizarre.